Searched for
STRIDES PHARMA SHARES
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST- Stock Radar: This pharma stock sees mild consolidation after 130% rally in 1 year; time to buy the dip?The pharma stock is a part of the S&P BSE Smallcap index. It saw an uptrend, rising from Rs 393 as of June 9, 2023, to Rs 901 recorded on J...12 Jun, 2024, 12.37 PM IST
- Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businessesAs per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. T...26 Sep, 2023, 12.17 PM IST
- Strides Pharma announces business rejig. Shares end 7% up, hit 52 week highThe announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday's...25 Sep, 2023, 05.07 PM IST
- Smallcap pharma stock jumps over 11% as arm receives tentative USFDA approval for HIV drug DolutegravirThe company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of whic...15 Sep, 2023, 12.45 PM IST
- Stride Pharma Science Q1 Results: Net loss narrows to Rs 163 croreRevenue from the US business in the June quarter stood at Rs 355.2 crore, up from Rs 301.6 crore last year.Similarly, the company said its ...29 Jul, 2022, 04.26 PM IST
- Accumulate Strides Pharma Science, target price Rs 355: GeojitStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2836.92 Crore) operating in Pha...24 Jun, 2022, 09.56 AM IST
- Buy Strides Pharma Science, target price Rs 355: EdelweissStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2914.80 Crore) operating in Pha...09 Mar, 2022, 09.07 AM IST
- Buy Strides Pharma, target price Rs 495: Motilal OswalThe brokerage expects earnings to triple over FY20–22, led by new product commercialization and higher volume share gains in existing produ...22 May, 2020, 01.02 PM IST
- Hold Strides Pharma, target price Rs 357: GeojitThe move to front end sales and systematic product launches in the US will be key triggers for the company in the future.17 Mar, 2020, 03.13 PM IST
- Strides plunges 8% as USFDA finds significant violation at facilityThe US drug regulator said it also found a blue binder containing CGMP records.17 Jul, 2019, 04.02 PM IST
- Strides Pharma arm signs pacts for sale of Australian business to Arrow PharmaThe company said it expects the transaction to close on or around July 10, 2019.01 Jul, 2019, 11.35 AM IST
- Sell Strides Pharma, target Rs 375: Manas JaiswalSell Strides Pharma at a price target of Rs 375 and a stoploss at Rs 406.20 Jun, 2019, 08.47 AM IST
- Buy Strides Pharma Science, target Rs 590: Motilal Oswal SecuritiesBuy Strides Pharma Science at a price target of Rs 590.30 Jan, 2019, 02.10 PM IST
- Buy Strides Pharma Science, target Rs 600: Manas JaiswalBuy Strides Pharma Science Ltd. at a price target of Rs 600.0 and a stoploss at Rs 525 from entry point.23 Jan, 2019, 09.18 AM IST
- Buy Strides Pharma Science, target Rs 535: Dr CK NarayanBuy Strides Pharma Science Ltd. at a price target of Rs 535.0 and a stoploss at Rs 515 from entry point.15 Jan, 2019, 08.59 AM IST
- Strides Pharma drops 3% on USFDA observation for Bengaluru plantThe observations are not material in nature, the company said.19 Sep, 2018, 10.26 AM IST
Load More
